Damian Kettlewell, CEO of Clairvoyant Therapeutics, Sits in the Investor Hotseat

Psychedelic Invest's Investor Hotseat returned to the main stage on Thursday, July 7th. Sitting in the hot seat this time was Damian Kettlewell of Clairvoyant Therapeutics.

While in the hot seat, Damian answered questions about Clairvoyant's psilocybin trials, their market size, capital allocation, and team (among other things).